Applications
PPG-Based Heart Failure Monitoring
PPG wearables provide non-invasive surrogates of hemodynamic status in heart failure patients through photoplethysmographic indices of cardiac output (pulse pressure proxy), pulmonary congestion indicators (peripheral perfusion, pulse wave changes), and autonomic dysfunction (severely blunted HRV). Continuous PPG monitoring can predict heart failure decompensation 3–7 days before clinical hospitalization.
How it works
Schematic summary of this guide. Waveforms are illustrative, not measured data.
Heart failure with reduced ejection fraction (HFrEF) produces characteristic PPG changes: reduced AC amplitude (low stroke volume → low pulse pressure), narrow pulse width (impaired ventricular relaxation), blunted dicrotic notch (increased systemic vascular resistance), and severely reduced HRV (cardiac sympathetic activation, neurohormonal activation).
The MC10 BioStamp and wrist PPG wearables have been used in prospective HF monitoring studies. The LINK-HF study (Stehlik et al. 2020, Circ Heart Fail, doi:10.1161/CIRCHEARTFAILURE.119.006513) monitored 100 patients after HF admission with a disposable multisensor chest patch; a machine-learning platform detected precursors of HF rehospitalization with 76% to 88% sensitivity and 85% specificity, a median 6.5 days before readmission.
Pulmonary congestion, the primary driver of HF hospitalization, does not directly alter peripheral PPG in ways that are fully validated. Impedance-based sensors (thoracic bioimpedance, implantable pressure monitors like CardioMEMS) remain superior for direct congestion monitoring. PPG-based HF monitoring is best positioned as an early warning supplement rather than a replacement for direct intracardiac pressure monitoring in high-risk patients.
Frequently Asked Questions
Can PPG detect heart failure decompensation before symptoms?
In the LINK-HF study, a multisensor chest patch with machine learning detected precursors of HF rehospitalization with 76% to 88% sensitivity and 85% specificity, a median 6.5 days before readmission. Whether this reduces hospitalizations has not yet been shown.
How does PPG differ in HFrEF vs HFpEF?
HFrEF (low ejection fraction) produces lower pulse amplitude and reduced AC/DC ratio due to decreased stroke volume. HFpEF (preserved EF) may show more subtle changes primarily in pulse wave morphology and diastolic timing, reflecting impaired ventricular relaxation rather than systolic dysfunction.
Is wearable PPG monitoring reimbursed for heart failure?
Remote patient monitoring (RPM) is reimbursable under CMS CPT codes 99453-99454 for established HF patients requiring biometric monitoring. PPG SpO2 devices can qualify under these codes when physician-ordered and properly documented, though specific device qualifications vary by payer.